T1	Participants 70 89	high-risk patients.
T2	Participants 158 179	fat embolism syndrome
T3	Participants 246 290	high-risk patients with long-bone fractures.
T4	Participants 410 474	corticosteroid- (0 of 21) and placebo-treated patients (9 of 41)
T5	Participants 1033 1084	patients at high risk for the fat embolism syndrome
